AIDS News and Research

RSS

Ranbaxy receives tentative FDA approval to manufacture and market Zidovudine tablets

India's Ranbaxy Laboratories has announced that it has received tentative approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market Zidovudine Tablets USP, 300 mg.

15 Jul 2005

Police shooting of AIDS protesters by South African police

AIDS Healthcare Foundation (AHF) today expressed its profound outrage over the unprovoked attack -- including what is believed to be the first-ever police shooting of AIDS protesters anywhere worldwide -- by South African police on AIDS activists conducting a peaceful protest.

15 Jul 2005

Scientists have identified the first reported case in Asia of primate-to-human transmission of simian foamy virus

...a retrovirus found in macaques and other primates that so far has not been shown to cause disease in humans.

13 Jul 2005

South Africa now 2nd only to India in HIV/AIDS cases

New figures from the South African Department of Health say more than 6.5 million of the country's 47 million people may now be HIV-positive.

12 Jul 2005

Age may work in reverse when it comes to raising grandchildren

...suggests a University of Florida study that finds younger grandmothers in this role are depressed more often than their older counterparts.

12 Jul 2005

California's medical marijuana program put on hold

As a direct result of a Supreme Court ruling last month that said the U.S. government could prosecute medical marijuana use, California officials say they will stop issuing identification cards to state residents who smoke marijuana to treat medical conditions.

11 Jul 2005

Researchers clarifiy role of Notch protein in T-cell development

Researchers at the University of Pennsylvania School of Medicine have recently clarified the role of the Notch protein in T-cell development. T cells are required for many aspects of immunity, including fighting viral infections, providing cancer surveillance, and regulating multiple aspects of the immune response.

6 Jul 2005

Ten million Africans treated by international disease treatment

A disease treatment programme started three years ago by Imperial College London has now treated over ten million African children and adults for schistosomiasis and intestinal worm infections in six sub-Saharan countries.

6 Jul 2005

Memory aids help people with schizophrenia remember things just as well as healthy people

When encouraged to use memorization strategies commonly employed by healthy individuals, people with schizophrenia can be helped to remember information just as well as their healthy counterparts, a process that in itself seems to spur a normalization of memory-related activities in the brains of people with schizophrenia, suggests new research from Washington University in St. Louis.

6 Jul 2005

G8 must focus on healthcare to save millions of lives

Millions of people are dying in the developing world because of poor access to cheap medicines and basic healthcare, the BMA says today (Wednesday, 6 July, 2005) ahead of the G8 summit.

6 Jul 2005

New law will take away vital medications from AIDS sufferers in Mississippi

Medicaid beneficiaries living with HIV/AIDS in Mississippi are about to be denied access to medications they need to stay alive.

1 Jul 2005

Report highlights importance of research into diseases in developing countries

Better drugs and vaccines are needed to fight HIV/AIDS, tuberculosis (TB), malaria and other tropical diseases. Pharmaceutical research has typically focussed on developing drugs, vaccines and other interventions for diseases prevalent in developed countries, where people can afford to buy treatments; it has tended to overlook those disorders that predominantly affect developing countries.

30 Jun 2005

Medicaid beneficiaries living with HIV/AIDS in Mississippi are about to be denied access to medications

A law that takes effect tomorrow, July 1, limits Mississippi Medicaid beneficiaries to two brand-name drugs. But controlling HIV infection requires three drugs, and all of them are brand name.

30 Jun 2005

Conservatives and sexual abstinence groups battle with FDA over condoms - they offer little protection against STD's

Although condoms are an effective method of contraception and stop the spread of AIDS, evidence that they protect against other sexually transmitted diseases is scant.

30 Jun 2005

If global efforts to prevent HIV/AIDS are to work long term, they must avoid suspicions of being unfair

Johns Hopkins infectious disease specialists who have spent more than two decades leading efforts to combat HIV and AIDS worldwide are warning that limited international relief supplies of antiretroviral therapies currently being distributed in Africa, Asia and the Caribbean will not get to those who can least afford to pay for them.

28 Jun 2005

Vaccine against Lassa fever works in monkeys

Scientists say that a genetically engineered virus may possibly offer the first effective vaccine against Lassa fever.

28 Jun 2005

Ethnicity makes little difference in the quality of outpatient care

A new study from the Stanford University School of Medicine has found that once U.S. patients visit a doctor for outpatient care, their race and ethnicity make little difference in the quality of care they receive.

28 Jun 2005

Infertility may be becoming more of a man's problem than a woman's problem

Until now, approximately 40% of infertility cases have been linked to medical problems in men and 40% to medical problems in women, with the remaining 20% due to joint problems.

27 Jun 2005

Gleevec or similar drugs might be useful in preventing adverse side effects of smallpox vaccine

Mice given a relatively new cancer drug can survive an otherwise lethal dose of vaccinia virus, a relative of smallpox virus, report scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID).

27 Jun 2005

Enzyme known as cathepsin G may be a target for anti-inflammatory treatments

The finding by researchers at Washington University School of Medicine in St. Louis shows that an enzyme known as cathepsin G regulates the ability of immune cells known as neutrophils to secrete chemicals that attract other immune cells and start the local inflammatory process. Over time, the excessive accumulation of immune cells can lead to tissue and cartilage damage in joints, causing pain and limiting mobility.

27 Jun 2005